Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Debt / NOTE 1.500% 3/1
-
Market price (% of par)
-
265.8%
-
Total 13F principal
-
$590,282,992
-
Principal change
-
-$3,852,072
-
Total reported market value
-
$1,570,217,000
-
Number of holders
-
31
-
Value change
-
+$201,857,873
-
Number of buys
-
19
-
Number of sells
-
47
Institutional Holders of SALIX PHARMACEUTICALS INC - NOTE 1.500% 3/1 as of Q1 2015
As of 31 Mar 2015,
SALIX PHARMACEUTICALS INC - NOTE 1.500% 3/1 was held by
31 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$590,282,992
in principal (par value) of the bond.
The largest 10 bondholders included
CAPSTONE INVESTMENT ADVISORS, LLC, Citadel Advisors LLC, OZ Management LP, TENOR CAPITAL MANAGEMENT Co., L.P., WOLVERINE ASSET MANAGEMENT LLC, FARALLON CAPITAL MANAGEMENT LLC, CITIGROUP INC, FMR LLC, Verition Fund Management LLC, and WELLS FARGO & COMPANY/MN.
This page lists
31
institutional bondholders reporting positions
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.